Velban (vinblastine) is a small molecule pharmaceutical. Vinblastine was first approved as Velban on 1982-01-01. It is used to treat breast neoplasms, choriocarcinoma, head and neck neoplasms, histiocytosis, and hodgkin disease amongst others in the USA. The pharmaceutical is active against tubulin beta chain.
|Indication||breast neoplasms, choriocarcinoma, head and neck neoplasms, histiocytosis, hodgkin disease, kaposi sarcoma, kidney neoplasms, lung neoplasms, mycosis fungoides, testicular neoplasms, thrombocytopenic purpura idiopathic|
|Drug Class||Antihistaminics (histamine-H1 receptor antagonists); vinca alkaloids|